175 related articles for article (PubMed ID: 30296357)
1. Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
Pennisi R; Albanesi J; Ascenzi P; Nervi C; di Masi A
IUBMB Life; 2018 Nov; 70(11):1057-1066. PubMed ID: 30296357
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis.
Qi W; Xu X; Wang M; Li X; Wang C; Sun L; Zhao D; Sun L
Biochem Pharmacol; 2019 Jun; 164():273-282. PubMed ID: 31014753
[TBL] [Abstract][Full Text] [Related]
3. Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Cagnetta A; Soncini D; Orecchioni S; Talarico G; Minetto P; Guolo F; Retali V; Colombo N; Carminati E; Clavio M; Miglino M; Bergamaschi M; Nahimana A; Duchosal M; Todoerti K; Neri A; Passalacqua M; Bruzzone S; Nencioni A; Bertolini F; Gobbi M; Lemoli RM; Cea M
Haematologica; 2018 Jan; 103(1):80-90. PubMed ID: 29025907
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia.
Salunkhe S; Mishra SV; Nair J; Ghosh S; Choudhary N; Kaur E; Shah S; Patkar K; Anand D; Khattry N; Hasan SK; Dutt S
Int J Cancer; 2018 May; 142(10):2175-2185. PubMed ID: 29297932
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells.
Ma J; Li X; Su Y; Zhao J; Luedtke DA; Epshteyn V; Edwards H; Wang G; Wang Z; Chu R; Taub JW; Lin H; Wang Y; Ge Y
Sci Rep; 2017 Feb; 7():41950. PubMed ID: 28176818
[TBL] [Abstract][Full Text] [Related]
6. The development of ataxia telangiectasia mutated kinase inhibitors.
Andrs M; Korabecny J; Nepovimova E; Jun D; Hodny Z; Moravcova S; Hanzlikova H; Kuca K
Mini Rev Med Chem; 2014; 14(10):805-11. PubMed ID: 25138084
[TBL] [Abstract][Full Text] [Related]
7. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.
Cheng X; Byrne M; Brown KD; Konopleva MY; Kornblau SM; Bennett RL; May WS
Blood; 2015 Sep; 126(13):1585-94. PubMed ID: 26202421
[TBL] [Abstract][Full Text] [Related]
8. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
9. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
[TBL] [Abstract][Full Text] [Related]
10. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
11. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y
Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972
[TBL] [Abstract][Full Text] [Related]
12. ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias.
Boudny M; Trbusek M
Cancer Treat Rev; 2020 Aug; 88():102026. PubMed ID: 32592909
[TBL] [Abstract][Full Text] [Related]
13. The DNA damage response pathway in normal hematopoiesis and malignancies.
Delia D; Mizutani S
Int J Hematol; 2017 Sep; 106(3):328-334. PubMed ID: 28707218
[TBL] [Abstract][Full Text] [Related]
14. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
Lam CF; Yeung HT; Lam YM; Ng RK
Leuk Res; 2018 May; 68():112-119. PubMed ID: 29609096
[TBL] [Abstract][Full Text] [Related]
17. Studying the cerebellar DNA damage response in the tissue culture dish.
Tzur-Gilat A; Ziv Y; Mittelman L; Barzilai A; Shiloh Y
Mech Ageing Dev; 2013 Oct; 134(10):496-505. PubMed ID: 23583690
[TBL] [Abstract][Full Text] [Related]
18. Suppression of DNMT1 combined with ATM or ATR inhibitor as a therapeutic combination of acute myeloid leukemia.
Liu L; Hu X; Feng J; Lei A; Huang S; Liu X; Liu H; Luo L; Yao W
Anticancer Drugs; 2024 Mar; 35(3):251-262. PubMed ID: 38164802
[TBL] [Abstract][Full Text] [Related]
19. ERK kinases modulate the activation of PI3 kinase related kinases (PIKKs) in DNA damage response.
Lin X; Yan J; Tang D
Histol Histopathol; 2013 Dec; 28(12):1547-54. PubMed ID: 23832672
[TBL] [Abstract][Full Text] [Related]
20. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.
Santos MA; Faryabi RB; Ergen AV; Day AM; Malhowski A; Canela A; Onozawa M; Lee JE; Callen E; Gutierrez-Martinez P; Chen HT; Wong N; Finkel N; Deshpande A; Sharrow S; Rossi DJ; Ito K; Ge K; Aplan PD; Armstrong SA; Nussenzweig A
Nature; 2014 Oct; 514(7520):107-11. PubMed ID: 25079327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]